Leske M C, Wu S Y, Nemesure B, Li X, Hennis A, Connell A M
Department of Preventive Medicine, University at Stony Brook, Stony Brook, New York 11794-8036, USA.
Ophthalmology. 2000 Jul;107(7):1267-73. doi: 10.1016/s0161-6420(00)00155-x.
To provide 4-year cumulative incidence and progression rates of age-related lens opacities in a population > or =40 years of age, which is mainly of African origin.
Cohort study that reexamined surviving members of the population-based Barbados Eye Study 4 years after baseline.
Three thousand four hundred twenty-seven members of the Barbados Eye Study cohort (85% of those eligible).
The Lens Opacities Classification System II (LOCS II) was used at the slit lamp. Cumulative incidence was defined as the development of any nuclear, cortical or posterior subcapsular (PSC) opacities (LOCS II scores > or =2) among persons without that opacity type at baseline. Cumulative progression was defined by at least two-step increases in scores among persons with preexisting lens opacities.
The incidence of cortical opacities was about five times greater in black than white participants (age-gender adjusted relative risk = 4.7; 95% confidence interval: 1.9-11.4). In the black population, the 4-year incidence rates were 22.2% (20.4%-24.0%) for any cortical, 9.2% (8.2%-10.4%) for any nuclear, and 3.3% (2.7%-4.0%) for any PSC opacities; rates increased greatly with age. Four-year progression rates were 12.5% for cortical, 3.6% for nuclear, and 23.0% for PSC opacities, without consistent pattern by age. Women had a greater risk of cortical and nuclear opacities (P<0.05) than men and greater progression of nuclear opacities. The presence of PSC opacities at baseline seemed to at least double the incidence and progression rates of other opacities. In persons initially opacity free, single cortical opacities were the predominant type to develop at followup. Visual acuity loss frequently accompanied incident opacities.
This longitudinal study provides new population-based data on the natural history of lens opacities. Incidence and progression of opacities, especially of cortical opacities, were high. After 4 years of followup, 1 in 4 to 5 participants developed cortical opacities, 1 in 11 developed nuclear opacities, and 1 in 30 developed PSC opacities. The information obtained attests to the public health impact of age-related cataract, as well as its extent, in this and similar black populations.
提供年龄≥40岁、主要为非洲裔人群中年龄相关性晶状体混浊的4年累积发病率和进展率。
队列研究,对基于人群的巴巴多斯眼病研究的存活成员在基线4年后进行重新检查。
巴巴多斯眼病研究队列中的3427名成员(占符合条件者的85%)。
在裂隙灯下使用晶状体混浊分类系统II(LOCS II)。累积发病率定义为基线时无该混浊类型的人群中出现任何核性、皮质性或后囊下(PSC)混浊(LOCS II评分≥2)。累积进展定义为已有晶状体混浊的人群中评分至少增加两步。
黑人参与者皮质混浊的发病率约为白人的5倍(年龄-性别调整后的相对风险=4.7;95%置信区间:1.9-11.4)。在黑人人群中,4年任何皮质性混浊的发病率为22.2%(20.4%-24.0%),任何核性混浊为9.2%(8.2%-10.4%),任何PSC混浊为3.3%(2.7%-4.0%);发病率随年龄大幅增加。4年皮质性混浊的进展率为12.5%,核性混浊为3.6%,PSC混浊为23.0%,无随年龄变化的一致模式。女性发生皮质性和核性混浊的风险高于男性(P<0.05),核性混浊进展更大。基线时存在PSC混浊似乎使其他混浊的发病率和进展率至少增加一倍。在最初无混浊的人群中,单一皮质性混浊是随访时最主要的发生类型。视力丧失常伴随新发混浊。
这项纵向研究提供了关于晶状体混浊自然史的新的基于人群的数据。混浊的发病率和进展,尤其是皮质性混浊,很高。经过4年随访,4至5名参与者中有1人发生皮质性混浊,11人中有1人发生核性混浊,30人中有1人发生PSC混浊。所获得的信息证明了年龄相关性白内障在该人群和类似黑人人群中的公共卫生影响及其程度。